Procept Biorobotics CORP Form 4 insider transactions

Hisham Shiblaq, EVP and Chief Commercial Officer of PROCEPT BioRobotics Corp, exercised stock options for 20,000 shares and simultaneously sold an equivalent number of shares for proceeds exceeding $1.2 million.

Antal Rohit Desai, a Director at PROCEPT BioRobotics Corp., sold 75,000 shares of common stock in early June 2025, pursuant to a Rule 10b5-1 trading plan established in November 2024.

Reza Zadno, CEO of Procept BioRobotics, exercised stock options on May 9, 2025, acquiring 13,759 shares of common stock at $7.27 per share.

Reza Zadno, CEO of PROCEPT BioRobotics, sold 5,475 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Kevin Waters, EVP and CFO of Procept BioRobotics Corp, sold 733 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Hisham Shiblaq, EVP and Chief Commercial Officer of Procept BioRobotics, sold 247 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Alaleh Nouri, EVP, CLO, and Corporate Secretary of Procept BioRobotics Corp, sold 316 shares of common stock on March 18, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Hisham Shiblaq, EVP and Chief Commercial Officer of Procept BioRobotics, sold 3,588 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Alaleh Nouri, EVP, CLO, and Corporate Secretary of Procept BioRobotics Corp, sold 3,641 shares of common stock on March 6, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Kevin Waters, EVP and CFO of Procept BioRobotics Corp, sold 3,662 shares of common stock on March 6, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

CEO Reza Zadno sold 15,916 shares of PROCEPT BioRobotics Corp to cover tax obligations related to vesting Restricted Stock Units.

Alaleh Nouri, EVP, CLO, and Corporate Secretary of Procept BioRobotics, reports acquisition and disposal of company stock and stock options.

Hisham Shiblaq, EVP and Chief Commercial Officer of PROCEPT BioRobotics Corp, reports acquisition of common stock and stock options.

Kevin Waters, EVP and CFO of Procept BioRobotics, reports acquisition of restricted stock units and stock options.

CEO Reza Zadno reports acquisition and disposal of common stock and acquisition of stock options in PROCEPT BioRobotics Corp.

Director Frederic Moll exercised stock options in PROCEPT BioRobotics Corp, acquiring shares at prices of $1.33 and $0.86.

Procept BioRobotics CEO Reza Zadno sold a total of 26,423 shares of common stock on December 4, 2024, under a pre-arranged 10b5-1 trading plan.

Alaleh Nouri, an executive at Procept BioRobotics, executed multiple transactions involving the sale of common stock and the exercise of stock options on December 4, 2024.

Procept BioRobotics CEO Reza Zadno sold a total of 26,420 shares of common stock on November 27, 2024, under a pre-arranged 10b5-1 trading plan.

Procept BioRobotics CEO Reza Zadno sold a total of 26,420 shares of common stock on November 20, 2024, under a pre-arranged 10b5-1 trading plan.

Procept BioRobotics CEO Reza Zadno sold a total of 26,420 shares of common stock on November 13, 2024, under a pre-arranged 10b5-1 trading plan.

Director Antal Rohit Desai reports multiple sales of Procept BioRobotics Corp (PRCT) stock between November 5th and November 7th, 2024, executed under a pre-arranged Rule 10b5-1 trading plan.

CEO Reza Zadno exercised stock options and sold shares of PROCEPT BioRobotics Corp on October 30, 2024.

EVP and CFO of Procept BioRobotics, Kevin Waters, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Kevin Waters, EVP and CFO of Procept BioRobotics, exercised stock options and sold shares of common stock on September 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Antal Rohit Desai of Procept BioRobotics Corp. sold shares of common stock between September 10 and September 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Antal Rohit Desai of Procept BioRobotics Corp. executed multiple sales of common stock between September 3rd and September 5th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Reza Zadno, CEO of Procept BioRobotics, exercised stock options on July 31, 2024, acquiring 23,484 shares of common stock at $4.37 per share.

Director Thomas M. Prescott reports acquisition of restricted stock units and stock options in PROCEPT BioRobotics Corporation.

Alaleh Nouri, EVP, CLO, and Corporate Secretary of Procept BioRobotics Corp, sold shares of common stock on June 17, 2024, under a pre-arranged 10b5-1 trading plan.